Correlation of Vitamin B12 with blood clotting in COVID-19 patients
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2021/02/030946
- Lead Sponsor
- GCS Medical College Hospital and Research Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.All patients who are COVID-19 positive by either COVID-19 RTPCR test or COVID-19 rapid antigen test or HRCT chest suggestive of active COVID-19 infection (CORADS III AND ABOVE)
2.All genders
3.Age above 18 years
4.Patients willing to give consent for this study
Exclusion Criteria
1.Patients who are COVID-19 negative
2.Patients who have taken Vitamin B12 supplements
3.Patients who might have raised D-Dimer due to other known causes; e.g. heart disease, prolonged bed rest, post surgical, etc
4.Pregnant and lactating women
5.Age <18 years
6.Patients not willing to give consent for this study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.To measure baseline Vitamin B12 levels in COVID19 positive patients <br/ ><br>2.To measure baseline D Dimer levels in these patients <br/ ><br>3.To measure maximum D Dimer levels in these patients through the course of hospital stay <br/ ><br>4.To analyse following in the study population: <br/ ><br> <br/ ><br>Duration of hospital stay <br/ ><br>Need for oxygen support <br/ ><br>Need for anticoagulation <br/ ><br>Clinical outcome(recovered/expired) <br/ ><br>Timepoint: 2 months
- Secondary Outcome Measures
Name Time Method To compare thrombotic events in persons with Vitamin B12 deficiency and in those with normal levelsTimepoint: 2 months